
A new AI tool could slash cancer drug research waiting times in half
However, while an ageing population means more cases than ever before, mortality rates are not rising at the same pace, thanks to the slow but steady flow of novel drugs approved each year. Targeted therapies, which act on cancer cells or the specific …